Christopher Gibson - Apr 7, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Apr 7, 2022
Transactions value $
-$147,375
Form type
4
Date filed
4/11/2022, 08:54 PM
Previous filing
Apr 8, 2022
Next filing
Apr 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Options Exercise $109K +44K +15.24% $2.48 333K Apr 7, 2022 Direct F1
transaction RXRX Class A Common Stock Sale -$119K -18.2K -5.47% $6.56 315K Apr 7, 2022 Direct F1, F2
transaction RXRX Class A Common Stock Conversion of derivative security $0 +18.5K +5.88% $0.00 333K Apr 7, 2022 Direct F1, F3, F4
transaction RXRX Class A Common Stock Sale -$121K -18.5K -5.55% $6.53 315K Apr 7, 2022 Direct F1, F5
transaction RXRX Class A Common Stock Conversion of derivative security $0 +500 $0.00 500 Apr 7, 2022 by LAHWRAN-3 LLC F1, F3, F4
transaction RXRX Class A Common Stock Sale -$3.25K -500 -100% $6.50 0 Apr 7, 2022 by LAHWRAN-3 LLC F1, F6
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1K $0.00 1K Apr 7, 2022 by LAHWRAN-4 LLC F1, F3, F4
transaction RXRX Class A Common Stock Sale -$6.51K -1K -100% $6.51 0 Apr 7, 2022 by LAHWRAN-4 LLC F1, F7
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1K $0.00 1K Apr 7, 2022 by Gibson Family Trust F1, F3, F4
transaction RXRX Class A Common Stock Sale -$6.52K -1K -100% $6.52 0 Apr 7, 2022 by Gibson Family Trust F1, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -18.5K -0.26% $0.00 6.99M Apr 7, 2022 Class A Common Stock 6.99M $0.00 Direct F1, F3, F4
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -44K -3.18% $0.00 1.34M Apr 7, 2022 Class A Common Stock 1.34M $2.47 Direct F1, F10
transaction RXRX Class B Common Stock Conversion of derivative security $0 -500 -0.09% $0.00 549K Apr 7, 2022 Class A Common Stock 549K $0.00 by LAHWRAN-3 LLC F1, F3, F4, F11
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1K -0.18% $0.00 547K Apr 7, 2022 Class A Common Stock 547K $0.00 by LAHWRAN-4 LLC F1, F3, F4, F12
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1K -0.69% $0.00 144K Apr 7, 2022 Class A Common Stock 144K $0.00 by Gibson Family Trust F1, F3, F4, F13
holding RXRX Stock Option (Right to Buy) 416K Apr 7, 2022 Class A Common Stock 416K $11.40 Direct F9
holding RXRX Stock Option (Right to Buy) 5.44K Apr 7, 2022 Class A Common Stock 5.44K $11.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $6.53 to $6.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Represents the conversion of Class B Common Stock into Class A Common Stock.
F4 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F5 This transaction was executed in multiple trades at prices ranging from $6.20 to $6.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $6.22 to $6.81. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $6.22 to $6.82. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $6.21 to $6.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F10 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F11 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F12 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F13 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.